The ImmunoScape team is heading to the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco in a few weeks. Our CEO Choon-Peng (Choon) Ng, our Vice President, Discovery Dan MacLeod, and our Senior Director, Business Development Christopher Alfonso will be in attendance to connect with industry colleagues and share our most recent progress on the development of novel TCR-based therapeutics using our Deep Immunomics platform. If you’re interested in meeting our team to learn more at the event, send us a message at info@immunoscape.com.
Meet us at the J.P. Morgan Healthcare Conference 2024
